Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
Clinical trial NCT03172754 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03172754
- Sponsor
- Fox Chase Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2026-11-06
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.